Clinical trials
3 active studies led by Crystalys Therapeutics, of 3 in all
Source: ClinicalTrials.gov, Studies with Crystalys Therapeutics (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show Crystalys Therapeutics in 2 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Crystalys Therapeutics or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
3 active studies led by Crystalys Therapeutics, of 3 in all
Source: ClinicalTrials.gov, Studies with Crystalys Therapeutics (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies Crystalys Therapeutics leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Crystalys Therapeutics or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Crystalys Therapeutics: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Crystalys Therapeutics is in.
Stories on the topics Crystalys Therapeutics works in.